FSK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FS KKR Capital Corp (FSK) is not a good buy right now for a Beginner focused on long-term investing, and I would not use new capital to add here. The stock has weak technical momentum, bearish analyst revisions, negative news flow, and no strong proprietary buy signal. With the current setup, the better decision is to avoid buying and wait for clearer stabilization.
Technically, FSK is weak. MACD histogram is negative and still widening, RSI_6 is 40.97, which is neutral but below the stronger momentum zone, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price is trading around 10.87 pre-market, below the pivot at 11.121 and only slightly above S1 at 10.667, which suggests limited near-term strength. The stock trend data also points to downside over the next week and month, reinforcing a bearish near-term setup.
Insiders are buying, and the buying amount increased 973.33% over the last month, which is the main positive sign. Pre-market price is slightly up 0.65%, showing some immediate stability. The options put-call ratios are not bearish enough to imply panic, and the stock still trades near support rather than breaking decisively lower.
Recent analyst action has been clearly negative, with multiple price target cuts and only hold/neutral-type ratings. RBC specifically lowered its target to $11 and cited credit impairments and a lower-than-expected Q2 base distribution. News also highlights a decline in net asset value, significant losses per share, and class action lawsuit activity, all of which weigh on sentiment. The technical trend is bearish, and similar-pattern data points to further weakness over the next week and month. AI Stock Picker and SwingMax both show no signal today.
The latest available quarter referenced in the data is Q2 2025. Financially, the company showed weaker fundamentals: net asset value declined, and there were significant losses per share. Analysts also flagged credit impairments, increased non-accruals, and pressure on net interest income. That indicates deteriorating growth and earnings quality rather than improving operating momentum.
Analyst sentiment is cautious to bearish. Recent targets were cut repeatedly: RBC moved to $11, Keefe Bruyette to $11, JPMorgan to $9.50, Truist to $11, B. Riley to $11, Wells Fargo to $11, and earlier RBC/KBW also cut estimates. Ratings are mostly Sector Perform, Market Perform, Neutral, or Hold. Wall Street’s pro view is that FSK remains cheap on book value and insider buying is positive; the con view is that earnings are uncertain, credit quality is weakening, dividend coverage is under pressure, and portfolio headwinds remain consistent. Overall, pros are outweighed by the cons.
